Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical outcomes of COVID‐19 infection among patients with Alzheimer's disease or mild cognitive impairment
Ying Wang, Mingfei Li, Lewis E. Kazis, et al.
Alzheimer s & Dementia (2022) Vol. 18, Iss. 5, pp. 911-923
Open Access | Times Cited: 21

Showing 21 citing articles:

Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 69
The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms
Feng Chen, Yan‐Ting Chen, Yongxiang Wang, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 45
Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms
Pei Huang, Linyuan Zhang, Yuyan Tan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Neurological complications caused by SARS-CoV-2
Zehan Pang, Ao Tang, Yujie He, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 6
Cognitive Aspects of COVID-19
Ezekiel Gonzalez‐Fernandez, Juebin Huang
Current Neurology and Neuroscience Reports (2023) Vol. 23, Iss. 9, pp. 531-538
Closed Access | Times Cited: 13
Early-life cognitively stimulating activities and late-life cognitive function in the St. Louis Baby Tooth Later Life Health Study
Andrea L. Roberts, Xinye Qiu, Kaleigh Ann McAlaine, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Association of memory function with COVID-19 outcomes in adults aged 50 years and older: Analysis of three prospective cohorts
Juanjuan Shi, Xin Shen, Tian Yan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Changes in cerebrovascular reactivity within functional networks in older adults with long-COVID
Jessica Pommy, Alexander D. Cohen, Amarpreet Mahil, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
ApoE4 causes severe COVID-19 outcomes via downregulation of ACE2
Feng Chen, Yanting Chen, Qiongwei Ke, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
Risk of Adverse Events and Delirium after COVID-19 Vaccination in Patients Living with Dementia
Edmund Chi Lok Cheung, Miriam T. Y. Leung, Kailin Chen, et al.
Journal of the American Medical Directors Association (2023) Vol. 24, Iss. 6, pp. 892-900.e12
Open Access | Times Cited: 7
Shared genetics and causal association between plasma levels of SARS‐CoV‐2 entry receptor ACE2 and Alzheimer's disease
Yan Zhang, Fang Xu, Tao Wang, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 2
COVID-19 and Alzheimer's Disease: Neuroinflammation, Oxidative Stress, Ferroptosis, and Mechanisms Involved
Alicia B. Pomilio, Arturo A. Vitale, Alberto Lazarowski
Current Medicinal Chemistry (2022) Vol. 30, Iss. 35, pp. 3993-4031
Closed Access | Times Cited: 11
Mortality and survival in nonagenarians during the COVID-19 pandemic: Unstable equilibrium of aging
Д. А. Каштанова, Veronika V. Erema, Maria S. Gusakova, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
SARS-CoV-2 and the Angiotensin-Converting Enzyme 2 Receptor: Angiotensin-Converting Enzyme Inhibitor/Angiotensin 2 Receptor Blocker Utilization and a Shift Towards the Renin-Angiotensin-Aldosterone System Classical Pathway
Randy Felber, William New, Suzanne I Riskin
Cureus (2024)
Open Access | Times Cited: 1
microRNA, the Innate-Immune System and SARS-CoV-2
James M. Hill, Walter J. Lukiw
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 7
Examining the immediate and ongoing impact of the COVID-19 pandemic on population-based estimates of dementia: a population-based time series analysis in Ontario, Canada
Aaron Jones, Susan E. Bronskill, Laura C. Maclagan, et al.
BMJ Open (2023) Vol. 13, Iss. 1, pp. e067689-e067689
Open Access | Times Cited: 3
Positive Effect of Cognitive Training in Older Adults with Different APOE Genotypes and COVID-19 History: A 1-Year Follow-Up Cohort Study
Yana Zorkina, Timur Syunyakov, Olga Abramova, et al.
Diagnostics (2022) Vol. 12, Iss. 10, pp. 2312-2312
Open Access | Times Cited: 4
Comparing COVID-19 vaccination coverage, adverse reactions and impact of social determinants of health on vaccine hesitancy in ADRD/MCI and non-ADRD/MCI population: protocol for a retrospective cross-sectional study
Yijiong Yang, Hyejin Park, Chengdong Li, et al.
BMJ Open (2024) Vol. 14, Iss. 7, pp. e082988-e082988
Open Access
COVID-19 Hospitalization Outcomes for Long-Term Care Facility Residents With Dementia: Mediation by Pre-existing Health Conditions
Cheng Yin, Elias Mpofu, Kaye Brock, et al.
Gerontology and Geriatric Medicine (2024) Vol. 10
Open Access
The Comparative Effectiveness of Monotherapy and Combination Therapies: Impact of Angiotensin Receptor Blockers on the Onset of Alzheimer’s Disease
Yan Wang, Mingqiang Li, Lewis E. Kazis, et al.
Journal of Aging Research and Lifestyle (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top